Southport Capital Management’s ResMed RMD Stock Holding History

Southport Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-869	Closed	-$226K	–	313
2021 Q4	$226K	Buy	+869	New	+$225K	0.04%	303
2021 Q3	–	Sell	-869	Closed	-$214K	–	286
2021 Q2	$214K	Buy	+869	New	+$183K	0.05%	289
2021 Q1	–	Sell	-968	Closed	-$206K	–	307
2020 Q4	$206K	Buy	+968	New	+$193K	0.07%	207

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Southport Capital Management's RMD Position: Q1 2022 in Review

Southport Capital Management sold out of ResMed (RMD) in Q1 2022, closing a stake of 869 shares — an estimated $226K sold.

Southport Capital Management first reported a position in RMD in Q4 2020 and held it in 3 quarters. The position peaked at $226K in Q4 2021. 683 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

Southport Capital Management reported no remaining ResMed position as of Q1 2022 after selling out during the quarter.
Southport Capital Management sold 869 ResMed shares in Q1 2022, an estimated $226K.
Southport Capital Management first reported a position in ResMed in Q4 2020 and held it in 3 quarters.
Southport Capital Management's ResMed position peaked at $226K in Q4 2021.
683 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.